Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci

Oritavancin possesses activity against vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA). In vitro data suggest synergy between beta-lactams (BLs) and vancomycin or daptomycin, agents similar to oritavancin. We evaluated the activities of BLs combined with...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Antimicrob Agents Chemother
Hoofdauteurs: Smith, Jordan R., Yim, Juwon, Raut, Animesh, Rybak, Michael J.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Microbiology 2016
Onderwerpen:
Experimental Therapeutics
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4808215/
https://ncbi.nlm.nih.gov/pubmed/26833159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03006-15
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items